Dr Varun Mehra, Consultant Haematologist
Dr Varun Mehra
Consultant Haematologist
Dr Varun Mehra MBBS, MRCP(UK), FRCPath
Consultant Haematologist
Dr Mehra is a Consultant Haematologist
Areas of expertise
- Haematological malignancy including Leukaemia, MDS, MPNs, lymphoma, myeloma and related disorder
- Low blood counts including marrow failure syndromes
- Stem cell Transplantation and associated complications
- HSCT in Autoimmune disorders
Make an appointment
Address
-
London Bridge Hospital
27 Tooley Street, London, SE1 2PR
-
Private Care at Guy's at London Bridge Hospital
Great Maze Pond, London, SE1 9RT
-
The Harley Street Clinic
35 Weymouth Street, London, W1G 8BJ
-
Video Consultation
Virtual, London, NW1 6JQ
About Dr Varun Mehra
GMC number: 6093838
Year qualified: 2002
Place of primary qualification: Maharashtra University of Medical Sciences and Health Services
Dr Varun Mehra is an accomplished and experienced consultant haematologist, specialising in myelodysplastic syndrome, acute leukaemia, bone marrow failure syndromes, and transplantation for autoimmune conditions. He has extensive training and expertise in the field, having completed his specialist haematology training at King's College Hospital in London and a fellowship in stem cell transplantation and cellular therapy. In addition to his clinical work, Dr Mehra is actively involved in research and education.
He has led several clinical research studies and has published his findings in high-impact clinical and scientific journals. His research interests include infections of immunocompromised hosts, graft versus host disease, and transplantation of autoimmune diseases. He is also involved in developing post-graduation modules for training in clinical haematology and disease-specific preceptorship programs. Dr Mehra is fully trained in CAR-T therapy, a new and highly specialised treatment for certain patients with relapsed high-grade B cell lymphomas and acute lymphoblastic leukaemia.
His passion for education and training is reflected in his roles as the current educational lead for the haematology specialist training program at King's College Hospital and his involvement in various specialist trainee committees and Royal College advisory groups. Dr Mehra's dedication to his field and his patients is evident in his comprehensive approach to treatment and his commitment to advancing medical knowledge through research and education. He has been serving at King's College Hospital, continually striving to improve patient outcomes and contribute to the medical community.
Professional memberships
Articles by Dr Varun Mehra
EBV and Monoclonal Gammopathy of Clinical Significance in Autologous Stem Cell Transplantation for Multiple Sclerosis
Improved outcomes following allogeneic hematopoietic stem cell transplantation in patients with DDX41-mutated myeloid neoplasms
Risk factor analysis of relapse risk during FLT3-inhibitor post-transplant maintenance therapy following allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia with FLT3-ITD
DDX41-related myeloid neoplasms: Insights and treatment landscape in 250 patients managed at a large tertiary centre
Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK
Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK
Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis
Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)
Real-world Effectiveness and Safety of Autologous Haematopoietic Stem Cell Transplantation in MS
Aspergillus calidoustus and Talaromyces columbinus infections in chronic graft-versus-host disease
Radiotracers for in situ infection imaging: Experimental considerations for in vitro microbial uptake of gallium-68-labeled siderophores
Disseminated Mucormycosis and T-Cell-Depleted Allogeneic Stem Cell Transplantation: An Unusual Case Study
The impact of the fungal priority pathogens list on medical mycology: A perspective from Northern Europe
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy
Myeloablative dose of busulfan and fludarabine combined with in vivo T-cell depletion is a safe and effective conditioning for acute myeloid leukaemia and myelodysplastic syndrome patients
